Device Trial Radar · NCT01754363
Survivorship of Attune Primary Total Knee Prosthesis
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,542
Actual
Start
Feb 1, 2013
Primary completion
Feb 1, 2030
Study completion Feb 1, 2030
Sponsor
- Lead sponsor
- DePuy InternationalPublic (JNJ)
- Sponsor type
- Industry
- First posted
- Dec 21, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset.
Conditions
- Noninflammatory Degenerative Joint Disease
Interventions
Attune Primary Total Knee ReplacementDevice
Patients will undergo a primary total knee replacement using one of the four configurations of the Attune knee (CR FB, CR RP, PS FB, PS RP).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survivorship of each configuration.Time frame: Minimum 15 years (5414 - 5658 days)
Locations
27 sites in 12 countries. Site status is shown where the registry gives one.
Mayo Clinic Arizona
Scottsdale, Arizona
Orthopaedic Specialty Institute
Orange, California
Florida Research Associates, LLC
DeLand, Florida
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.